Protective Effect of Jolkinolide B on Lps-Induced Mouse Acute Lung Injury

Hailing Yang,Yan Li,Pengfei Huo,Xiao-ou Li,Daliang Kong,Wei Mu,Wei Fang,Lingxia Li,Ning Liu,Ling Fang,Hongjun Li,Chengyan He

DOI: https://doi.org/10.1016/j.intimp.2015.03.021

IF: 5.714

2015-01-01

International Immunopharmacology

Abstract:Jolkinolide B (JB), an ent-abietane diterpenoid, isolated from the dried root of Euphorbia fischeriana, has been reported to have potent anti-tumor and anti-inflammatory activities. However, the effects of JB on acute lung injury (ALI) and underlying molecular mechanisms have not been investigated. The present study aimed to investigate the effect of JB on lipopolysaccharide (LPS)-induced ALI. Male C57BL/6 mice were pretreated with dexamethasone or JB 1h before intranasal instillation of LPS. The results showed that JB markedly attenuated LPS-induced histological alterations, lung edema, inflammatory cell infiltration, myeloperoxidase (MPO) activity as well as the production of TNF-α, IL-6 and IL-1β. Furthermore, JB also significantly inhibited LPS-induced the degradation of IκBα and phosphorylation of NF-κB p65 and MAPK. Therefore, our study provides the first line of evidence that pretreatment of JB has a protective effect on LPS-induced ALI in mice. The anti-inflammatory mechanism of JB may be attributed to its suppression of NF-κB and MAPK activation.